M Metcalfe

1.2k total citations
30 papers, 526 citations indexed

About

M Metcalfe is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, M Metcalfe has authored 30 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 18 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Biomedical Engineering. Recurrent topics in M Metcalfe's work include Cardiac Imaging and Diagnostics (18 papers), Advanced MRI Techniques and Applications (9 papers) and Cardiovascular Function and Risk Factors (7 papers). M Metcalfe is often cited by papers focused on Cardiac Imaging and Diagnostics (18 papers), Advanced MRI Techniques and Applications (9 papers) and Cardiovascular Function and Risk Factors (7 papers). M Metcalfe collaborates with scholars based in United Kingdom, Slovakia and Canada. M Metcalfe's co-authors include K Jennings, John Rawles, Gregory Y.H. Lip, Francis G. Dunn, H. G. Gemmell, Graham S. Hillis, G Mowatt, Miriam Brazzelli, Luke Vale and Ann Rumley and has published in prestigious journals such as European Heart Journal, The American Journal of Cardiology and Heart.

In The Last Decade

M Metcalfe

28 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Metcalfe United Kingdom 12 350 195 84 53 38 30 526
Elena Corrada Italy 12 223 0.6× 82 0.4× 121 1.4× 55 1.0× 23 0.6× 41 340
F Rovelli Italy 8 583 1.7× 161 0.8× 168 2.0× 28 0.5× 39 1.0× 29 680
Gerry Devlin New Zealand 12 399 1.1× 58 0.3× 69 0.8× 34 0.6× 39 1.0× 47 508
Sima Welber Israel 9 392 1.1× 175 0.9× 212 2.5× 28 0.5× 46 1.2× 18 503
Carlos Macaya Miguel Spain 8 590 1.7× 275 1.4× 280 3.3× 20 0.4× 35 0.9× 32 657
Jay Shavadia Canada 14 331 0.9× 89 0.5× 167 2.0× 68 1.3× 35 0.9× 46 513
Norman Briffa United Kingdom 12 268 0.8× 55 0.3× 257 3.1× 33 0.6× 110 2.9× 49 522
Valerio Verdiani Italy 11 460 1.3× 35 0.2× 69 0.8× 42 0.8× 85 2.2× 18 536
Marie Hauguel‐Moreau France 11 378 1.1× 138 0.7× 255 3.0× 34 0.6× 52 1.4× 38 563
Jacobo Silva Spain 13 634 1.8× 122 0.6× 201 2.4× 39 0.7× 164 4.3× 79 772

Countries citing papers authored by M Metcalfe

Since Specialization
Citations

This map shows the geographic impact of M Metcalfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Metcalfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Metcalfe more than expected).

Fields of papers citing papers by M Metcalfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Metcalfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Metcalfe. The network helps show where M Metcalfe may publish in the future.

Co-authorship network of co-authors of M Metcalfe

This figure shows the co-authorship network connecting the top 25 collaborators of M Metcalfe. A scholar is included among the top collaborators of M Metcalfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Metcalfe. M Metcalfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forbes, Ken J., et al.. (2009). Food–the way to a man's heart: A mini-case series of Campylobacter perimyocarditis. Scandinavian Journal of Infectious Diseases. 41(6-7). 528–531. 3 indexed citations
2.
Egred, Mohaned, Gordon D. Waiter, Scott I. Semple, et al.. (2006). Blood oxygen level-dependent (BOLD) magnetic resonance imaging in patients with dypiridamole induced ischemia; a PET comparative study. European Heart Journal. 27. 415–416.
3.
Egred, Mohaned, Gordon D. Waiter, Thomas W. Redpath, et al.. (2006). Blood oxygen level-dependent (BOLD) magnetic resonance imaging in patients with dypiridamole induced ischaemia; a PET comparative study. International Journal of Cardiology. 115(1). 36–41. 6 indexed citations
4.
Kelion, Andrew, Constantinos Anagnostopoulos, Mark Harbinson, S. Richard Underwood, & M Metcalfe. (2005). Myocardial perfusion scintigraphy in the UK: insights from the British Nuclear Cardiology Society Survey 2000. Heart. 91(suppl 4). iv2–iv5. 19 indexed citations
5.
Mowatt, G, Miriam Brazzelli, H. G. Gemmell, et al.. (2005). Systematic review of the prognostic effectiveness of SPECT myocardial perfusion scintigraphy in patients with suspected or known coronary artery disease and following myocardial infarction. Nuclear Medicine Communications. 26(3). 217–229. 31 indexed citations
6.
Peace, Richard, Roger T. Staff, H. G. Gemmell, Fergus McKiddie, & M Metcalfe. (2002). Automatic detection of coronary artery disease in myocardial perfusion SPECT using image registration and voxel to voxel statistical comparisons. Nuclear Medicine Communications. 23(8). 785–794. 3 indexed citations
7.
Metcalfe, M, et al.. (2000). The accuracy of non-invasive methods for the detection of obstructive coronary artery disease in the presence of left ventricular hypertrophy. Journal of Human Hypertension. 14(5). 295–298. 5 indexed citations
8.
Allman, Kevin C., J. Lekakis, Sharon Watanabe, et al.. (2000). Do you need to combine exercise with dipyridamole? Is this your routine practice? How do you deal with the reverse redistribution pattern? Is it a clinically relevant issue?. PubMed. 7(4). 403–4. 1 indexed citations
9.
McNeish, Iain A., et al.. (1996). Visualization of cardiac emboli from mitral valve papillary fibroelastoma.. PubMed. 27(6). 1133–4. 16 indexed citations
10.
Lip, Gregory Y.H., Gordon Lowe, M Metcalfe, Ann Rumley, & Francis G. Dunn. (1995). Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. The American Journal of Cardiology. 76(7). 453–458. 41 indexed citations
12.
Lip, Gregory Y.H., Gordon Lowe, M Metcalfe, Ann Rumley, & Francis G. Dunn. (1995). Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease. International Journal of Cardiology. 50(1). 31–42. 11 indexed citations
13.
14.
Lip, Gregory Y.H., M Metcalfe, & Francis G. Dunn. (1993). Diagnosis and treatment of digoxin toxicity. Postgraduate Medical Journal. 69(811). 337–339. 24 indexed citations
15.
Lip, G Y H, et al.. (1993). Management of paroxysmal atrial fibrillation. QJM. 86(8). 467–472. 11 indexed citations
17.
Rawles, John, M Metcalfe, & K Jennings. (1990). Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.. Heart. 63(4). 225–227. 116 indexed citations
18.
Rawles, John, et al.. (1990). Association of patient delay with symptoms, cardiac enzymes, and outcome in acute myocardial infarction. European Heart Journal. 11(7). 643–648. 24 indexed citations
20.
Metcalfe, M, et al.. (1988). Does cardioversion of atrial fibrillation result in myocardial damage?. BMJ. 296(6633). 1364–1364. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026